Sean D. Sullivan

faculty photo
The fertility of our minds to invent health care technology must now be matched by a commitment to assess and identify its appropriate use.
Professor, Health Services
Professor, Department of Pharmacy (primary appt.)
Adjunct Professor, Allergy and Infectious Dis.


PhD   University of California (Berkeley), 1992   (Health Economics)
MS   University of Texas (Austin), 1986   (Pharmacy)
BS   Oregon State University, 1983   (Pharmacy)

Contact Info


office:   H-375, Health Sciences Building

1959 NE Pacific Street
Seattle, WA 98195-7630

campus box:   357630
voice:   206-685-8153
fax:   206-543-3835


Sean D. Sullivan, BScPharm, MSc, PhD, is Professor and Associate Dean for Research at the University of Washington School of Pharmacy. He holds a joint appointment as Professor of Health Services in the School of Public Health, is Director of the UW Pharmaceutical Outcomes Research and Policy Program (PORPP) and co-Director of the University of Washington Centers for Comparative and Health Systems Effectiveness (CHASE Alliance). He holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.

He completed his bachelor's degree in pharmacy from Oregon State University in 1983, master's degree in administrative and economic sciences from the University of Texas in 1986 and PhD in health economics and policy from the University of California-Berkeley in 1991.

Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions - the United States evidence-based guidelines for formulary decision-making.

Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.

Technology assessment; medical decision making; economic evaluation of pharmaceuticals, particularly in the areas of respiratory disorders, organ transplantation, HIV/AIDS, mental health and clinical decision making

SciVal Experts Profile

Carlson JJ, Gries K, Yeung K, Sullivan SD, Garrison LP. Authors' Reply to Curto and Garattini: "Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers". Appl Health Econ Health Policy. 2014 Aug 16. [Epub ahead of print]  PMID: 25124263

Seal B, Sullivan SD, Ramsey SD, Asche CV, Shermock K, Sarma S, Zagadailov EA, Farrelly E, Eaddy M. Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases. Appl Health Econ Health Policy. 2014 Jul 9. [Epub ahead of print]  PMID: 25005491

Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD, Bauer Z, Bresnahan BW, Avins AL, Nedeljkovic SS, Nerenz DR, Standaert C, Kessler L, Akuthota V, Annaswamy T, Chen A, Diehn F, Firtch W, Gerges FJ, Gilligan C, Goldberg H, Kennedy DJ, Mandel S, Tyburski M, Sanders W, Sibell D, Smuck M, Wasan A, Won L, Jarvik JG. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014 Jul 3;371(1):11-21. doi: 10.1056/NEJMoa1313265.  PMID: 24988555

Levy AR, Perkins RM, Johnston KM, Sullivan SD, Sood VC, Agnese W, Schnitzler MA. An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease. Int J Nephrol Renovasc Dis. 2014 Jul 3;7:271-80. doi: 10.2147/IJNRD.S58074. eCollection 2014.  PMID: 25061330    PMCID: PMC4086666

Hoogendoorn M, Feenstra TL, Asukai Y, Borg S, Hansen RN, Jansson SA, Samyshkin Y, Wacker M, Briggs AH, Lloyd A, Sullivan SD, Rutten-van Mölken MP. Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios. Value Health. 2014 Jul;17(5):525-36. doi: 10.1016/j.jval.2014.03.1721. Epub 2014 May 14.  PMID: 25128045

view books/publications in WorldCat

Chair, thesis committee for Junho Jang
Cost and health status outcome among adult asthma patients: MEPS 2000-2009

ARRA UW Centers for Comparative and Health Systems Effectiveness Training Program
Agency for Healthcare Research and Quality (AHRQ)
PI:   Sullivan           Dates:    10/1/2010 - 9/30/2013